Concepedia

Harry Samaroo

HS

Statistics

Publications

4

Citations

516

H-Index

4

Active since

2011

Affiliations

Pfizer (United States)(Current)

Harry Samaroo is an author at Pfizer (United States) specializing in neuroscience, life sciences, and molecular neuroscience.

Publications per year

2011–2015

4

Publications

4

Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression

Anastasia G. Henry, Soheil Aghamohammadzadeh, Harry Samaroo et al. · Human Molecular Genetics · 2015 · 249 citations · Full text

, , +15

Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis

Diane Stephenson, Sharon O'Neill, Sapna Narayan et al. · Molecular Autism · 2011 · 179 citations · Full text

, , +17

Phosphoproteomic evaluation of pharmacological inhibition of leucine‐<scp>rich</scp> repeat kinase 2 reveals significant off‐target effects of <scp>LRRK</scp>‐2‐<scp>IN</scp>‐1

Gregory C. Luerman, Chuong Nguyen, Harry Samaroo et al. · Journal of Neurochemistry · 2013 · 66 citations · Full text

, , +15

High throughput object-based image analysis of β-amyloid plaques in human and transgenic mouse brain

Harry Samaroo, Alan Opsahl, Jan Schreiber et al. · Journal of Neuroscience Methods · 2011 · 22 citations

, , +16

1–4 of 4